Evidence map›Paper›PMID 36899043›Full record

ArticleScientific reports2023

Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use.

Jordan Sibeoni, Emilie Manolios, Clement Hausser, Raphael Delage, Franck Baylé, Mario Speranza, Laurence Verneuil, Anne Revah-Levy

Full text read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jordan SibeoniService Universitaire de Psychiatrie de l'Adolescent, Argenteuil Hospital Centre, 69 rue du Ltc Prud'hon, 95100, Argenteuil, France. jordansib@hotmail.com.
Emilie ManoliosECSTRRA Team, UMR-1153, Inserm, Université Paris Cité, 75010, Paris, France.
Clement HausserService Universitaire de Psychiatrie de l'Adolescent, Argenteuil Hospital Centre, 69 rue du Ltc Prud'hon, 95100, Argenteuil, France.
Raphael DelageECSTRRA Team, UMR-1153, Inserm, Université Paris Cité, 75010, Paris, France.
Franck BayléECSTRRA Team, UMR-1153, Inserm, Université Paris Cité, 75010, Paris, France.
Mario SperanzaService Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Centre Hospitalier de Versailles, 177 Rue de Versailles, 78150, Le Chesnay-Rocquencour, France.
Laurence VerneuilECSTRRA Team, UMR-1153, Inserm, Université Paris Cité, 75010, Paris, France.
Anne Revah-LevyService Universitaire de Psychiatrie de l'Adolescent, Argenteuil Hospital Centre, 69 rue du Ltc Prud'hon, 95100, Argenteuil, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many studies have demonstrated the short-term efficacy and tolerability of methylphenidate treatment adolescents with attention deficit hyperactivity disorder (ADHD). Qualitative literature on this matter focused on school outcomes, long-term side effects, family conflicts, personality changes and stigmatization. Yet, no qualitative study has crossed the perspectives of child and adolescent psychiatrists (CAPs) prescribing methylphenidate and adolescents with ADHD. This French qualitative study followed the five stages IPSE-Inductive Process to analyze the Structure of lived Experience-approach. Fifteen adolescents with ADHD and 11 CAPs were interviewed. Data collection by purposive sampling continued until data saturation was reached. Data analysis, based on a descriptive and structuring procedure to determine the structure of lived experience characterized by the central axes of experience, produced two axes: (1) The process of methylphenidate prescription, highlighting how this prescription was motivated from the exterior, experienced as passive by the adolescents and required commitment from the CAPs; and (2) the perceived effects of methylphenidate treatment, in three domains: at school, in relationships and in the sense of self. Findings raised both the issues of the epistemic position and social representation of the adolescents about ADHD and methylphenidate within this specific French context, and the self-awareness and perception of the adolescents with ADHD. We conclude that these two issues need to be regularly addressed by the CAPs prescribing methylphenidate to avoid epistemic injustice and prevent the harmful effects of stigmatization.

Indexed as

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsMethylphenidatePsychiatryAdolescentChildHumansPrescriptionsCentral Nervous System StimulantsMethylphenidate

Identifiers

PMID36899043
PMCPMC10006242

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read26
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.